Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Epilepsy

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 11 articles:
HTML format
Text format



Single Articles


    April 2019
  1. SILBERGLEIT R, Elm JJ
    Levetiracetam no better than phenytoin in children with convulsive status epilepticus.
    Lancet. 2019 Apr 17. pii: S0140-6736(19)30896.
    PubMed     Text format    


  2. DALZIEL SR, Borland ML, Furyk J, Bonisch M, et al
    Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Lancet. 2019 Apr 17. pii: S0140-6736(19)30722.
    PubMed     Text format     Abstract available


  3. LYTTLE MD, Rainford NEA, Gamble C, Messahel S, et al
    Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lancet. 2019 Apr 17. pii: S0140-6736(19)30724.
    PubMed     Text format     Abstract available


    February 2019
  4. THE LANCET
    From wonder and fear: make epilepsy a global health priority.
    Lancet. 2019;393:612.
    PubMed     Text format    


    January 2019
  5. THIJS RD, Surges R, O'Brien TJ, Sander JW, et al
    Epilepsy in adults.
    Lancet. 2019 Jan 24. pii: S0140-6736(18)32596.
    PubMed     Text format     Abstract available


    August 2018
  6. SEN A, Nashef L
    New regulations to cut valproate-exposed pregnancies.
    Lancet. 2018;392:458-460.
    PubMed     Text format    


    July 2018
  7. THE LANCET
    Cannabinoids: just like any other medication?
    Lancet. 2018;392:188.
    PubMed     Text format    


    March 2018
  8. VARADKAR S
    Cannabidiol for drop seizures in Lennox-Gastaut syndrome.
    Lancet. 2018;391:1006-1007.
    PubMed     Text format    


  9. THIELE EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, et al
    Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Lancet. 2018;391:1085-1096.
    PubMed     Text format     Abstract available


    October 2016
  10. BAYER R, Johns DM, Galea S
    A false aura of scientific controversy around salt?
    Lancet. 2016;388:2109.
    PubMed     Text format    


  11. FRENCH JA, Lawson JA, Yapici Z, Ikeda H, et al
    Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
    Lancet. 2016;388:2153-2163.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: